Oncology Times - OncTimes Talk

Oncology Times - OncTimes Talk

Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care professionals. Learn more about our award-winning journal!
200 episodios disponibles

Latest episodes of the podcast Oncology Times - OncTimes Talk

Mostrando página 4 de 10

mRNA Vaccine + Checkpoint Inhibitor Combo Had Low Toxicity With Evidence of Efficacy in Advanced NSCLC 28/05/2024
Bispecific Dual Checkpoint Blockade Extends Life & Slows Progression in Gastric & GE Junction Cancers 16/05/2024
Clinical Study Shows Selective PARP 1 Inhibitor More Effective, Less Toxic 16/05/2024
Exercise Deters Prostate Cancer Death & Progression 16/05/2024
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma 02/05/2024
Exosome-Based Liquid Biopsy Promises Very Early Pancreatic Cancer Detection 02/05/2024
Polyepitopic Personalized Vaccine Brought Durable Immune Responses & Clinical Benefit in Resected Head & Neck Cancers 02/05/2024
Mesh-Supported Prepectoral Method of Breast Reconstruction After Breast Cancer Surgery 29/04/2024
Radiotherapy Boost Protects Young Patients With Early Breast Cancer, High Dose Boost Not Needed 29/04/2024
Breast-Conserving Therapy Effective for Ductal Carcinoma in Situ, But Questions Remain 26/04/2024
Three-Node Breast Cancer Spread: Most Patients Can Safely Avoid Axillary Dissection 26/04/2024
Artificial Intelligence Tool Predicts Postoperative Radiotherapy Lymphedema 15/04/2024
Neoadjuvant Pembrolizumab Improves High-Risk Early Breast Cancer Outcomes 15/04/2024
Preoperative Partial Breast Irradiation: Marked Benefit in Low-Risk Breast Cancer 12/04/2024
Adjuvant Atezolizumab: No Survival Benefit in Triple-Negative Breast Cancer 11/04/2024
Gene Test Shows Which Triple-Negative Breast Cancers Do Not Need Pre-Op Pembrolizumab 27/03/2024
Triple Therapy for Patients With Mutated FLT3 Gene in Acute Myeloid Leukemia 22/03/2024
Important Mantle Cell Lymphoma Findings From the Sympatico Study 12/03/2024
World’s Largest Prostate Cancer Trial, STAMPEDE, Celebrates 20 Years of Progress 06/03/2024
Doublet Inhibitor Therapy Restrains Metastatic EGFR-Mutated NSCLC Progression 04/03/2024
« Primera ‹ Anterior 1 2 3 4 5 6 ... 10 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA